At the tumor microenvironment, TRP catabolism is promoted by indoleamine 2,3-dioxygenase (IDO1) overexpression under pro-inflammatory conditions, and it plays an important role in modulating antitumor immune response (18–20). The gene discussed is IDO1; the disease is neoplasm.